Accession Number:

AD1166364

Title:

NY-ESO-1-specific TCR-engineered T-cell Immunotherapy for Triple Negative Breast Cancer

Descriptive Note:

[Technical Report, Annual Report]

Corporate Author:

METHODIST HOSPITAL HOUSTON TX

Personal Author(s):

Report Date:

2021-10-01

Pagination or Media Count:

26

Abstract:

Subject Categories:

Distribution Statement:

[A, Approved For Public Release]